Literature DB >> 6664184

[Prognosis of follicular thyroid cancer in the Tyrolean endemic goiter area].

D Ladurner, F Hofstädter.   

Abstract

89 follicular thyroid cancers (from 1952 to 1975) with detailed histology, complete clinical data and follow-up were analysed by several variables of which some prognostic importance could be expected. The observed survival times range from 0.08 to 27.75 years. Observed cumulative and expected survival rates were calculated and evaluated statistically. Evaluation of individual prognosis naturally demands a combination of histological, macropathological and clinical data: extent of primary tumor, capsular penetration and vascular infiltration, lymphnode involvement and distant metastases proved to be important parameters. The classification in intra-and extrathyroid carcinoma is to be preferred to the T-classification of the UICC, because it is simple and of great prognostic value.

Entities:  

Mesh:

Year:  1983        PMID: 6664184     DOI: 10.1007/bf01257430

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  13 in total

1.  Maximum utilization of the life table method in analyzing survival.

Authors:  S J CUTLER; F EDERER
Journal:  J Chronic Dis       Date:  1958-12

2.  Value of histologic classification of thyroid cancer.

Authors:  K Franssila
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1971

3.  A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group.

Authors:  D P Byar; S B Green; P Dor; E D Williams; J Colon; H A van Gilse; M Mayer; R J Sylvester; M van Glabbeke
Journal:  Eur J Cancer       Date:  1979-08       Impact factor: 9.162

4.  Papillary thyroid carcinoma: the impact of therapy in 576 patients.

Authors:  E L Mazzaferri; R L Young; J E Oertel; W T Kemmerer; C P Page
Journal:  Medicine (Baltimore)       Date:  1977-05       Impact factor: 1.889

Review 5.  [Early diagnosis of thyroid cancer in endemic goitre area reflections and management based on the epidemiological situation in Tyrol (author's transl)].

Authors:  D Ladurner; W Zechmann
Journal:  Wien Klin Wochenschr       Date:  1982-03-05       Impact factor: 1.704

6.  Thyroid carcinoma: a clinical and pathologic study of 125 cases.

Authors:  C M Frauenhoffer; A S Patchefsky; A Cobanoglu
Journal:  Cancer       Date:  1979-06       Impact factor: 6.860

7.  Risk factor analysis in differentiated thyroid cancer.

Authors:  B Cady; C E Sedgwick; W A Meissner; M S Wool; F A Salzman; J Werber
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

8.  Prognosis in thyroid carcinoma.

Authors:  K O Franssila
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860

9.  Papillary thyroid carcinomas. Morphology and prognosis.

Authors:  J Tscholl-Ducommun; C E Hedinger
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  4 in total

1.  European endocrine surgery in the 150-year history of Langenbeck's Archives of Surgery.

Authors:  Henning Dralle; A Machens
Journal:  Langenbecks Arch Surg       Date:  2010-03-09       Impact factor: 3.445

2.  [Surgery of metastases of differentiated thyroid cancers].

Authors:  H D Röher; P E Goretzki; R A Wahl
Journal:  Langenbecks Arch Chir       Date:  1987

3.  [Papillary thyroid cancer--prognosis and prognostic factors].

Authors:  D Ladurner; G Seeber; F Hofstädter
Journal:  Langenbecks Arch Chir       Date:  1984

4.  [Morphology and prognosis of follicular thyroid cancer--a clinico-pathologic and DNA cytometric study of 95 tumors].

Authors:  S Schröder; H Baisch; W Rehpenning; H W Müller-Gärtner; K Schulz-Bischof; B Sablotny; I Meiners; W Böcker; H W Schreiber
Journal:  Langenbecks Arch Chir       Date:  1987
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.